From left: Dr. Kerry Lavender (PhD) and Dr. Joyce Wilson (PhD). (Photos: Submitted)

USask researchers explore therapeutics to fight COVID-19

Posted on

With COVID-19 ravaging the globe, the race is on to accelerate therapeutics research and find effective treatment options.

Two research teams in the College of Medicine at the University of Saskatchewan (USask) are hoping their work will do just that.

Dr. Kerry Lavender (PhD) and Dr. Joyce Wilson (PhD) are principal investigators of projects that received Canadian Institutes of Health Research (CIHR) rapid response funding. The funding initiative contributes to the national research response to the COVID-19 pandemic.

Lavender’s project is rapidly evaluating some highly promising therapeutics against COVID-19, using a humanized mouse model…..

Read More Impact Stories

Posted on
McGill-developed device offers 100 per cent accuracy in as little as 10 minutes, and can be configured to detect a [...]
Posted on
This content is available in French only.
Posted on
The University of Toronto and Moderna, Inc. known for its mRNA-based COVID-19 vaccine plan to work together to develop new [...]